首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Re: 'Initial experience with the 5x300-mm proteus embolic capture angioplasty balloon in the treatment of peripheral vascular disease'
【24h】

Re: 'Initial experience with the 5x300-mm proteus embolic capture angioplasty balloon in the treatment of peripheral vascular disease'

机译:回复:“ 5x300毫米变形蛋白栓塞捕获血管成形术球囊治疗周围血管疾病的初步经验”

获取原文
获取原文并翻译 | 示例
       

摘要

It is with great interest that we read the article by Zeller and colleagues, which described their experience using an embolic capture angioplasty (ECA) balloon catheter in TASC II (TransAtlantic Inter-Society Consensus) C and D femoropopliteal interventions. Distal embolization during percutaneous arterial interventions is a major concern due to potential severe ischemic consequences. The incidence of significant embolization in infrainguinal interventions has been estimated at 1% to 5%. Given the increasing number and complexity of lower extremity interventions, there is growing interest in discussing when and how to use embolic protection devices (EPDs), which have been used with success in carotid, coronary, and renal artery interventions and have become the standard of care in some circumstances.2 However, any conclusion that the ECA device was an effective tool for avoiding embolic events in long peripheral lesions and might be considered as part of routine clinical practice for complex TASC II C/D femoropopliteal lesions should be viewed with caution.
机译:非常有趣的是,我们阅读了Zeller及其同事的文章,该文章描述了他们在TASC II(跨大西洋社会间共识)C和D股pop动脉干预中使用栓塞捕获血管成形术(ECA)球囊导管的经验。由于潜在的严重缺血性后果,经皮动脉介入治疗中的远端栓塞是一个主要问题。据估计,在介入治疗中发生明显栓塞的发生率为1%至5%。鉴于下肢干预的数量和复杂性日益增加,人们越来越关注讨论何时以及如何使用栓塞保护装置(EPD),该栓塞保护装置已成功用于颈动脉,冠状动脉和肾动脉干预,并已成为栓塞保护装置的标准。 2然而,任何认为ECA装置是避免长周边病变中发生栓子事件的有效工具,并可能被视为复杂TASC II C / D股pop骨病变常规临床实践的一部分的结论都应谨慎对待。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号